Modern living. Test 1

Match the verbs to their translations.

Match the nouns to their synonyms.

Match the careers to the funtcions.

Fill in the gaps with the correct words. There are two extra words. Henry, a creative young boy passionate about VR development, faced opposition from his father, a businessman who wanted him to follow a more conventional in public service. Despite his father's , Henry pursued his dream, supported by his girlfriend. At design school, he struggled but persevered, refining his skills in 3D modeling, storytelling, and . His dedication paid off when he worked on a high-profile VR project, earning widespread and industry recognition. Henry's success led to job offers and prestigious , proving that determination and passion could overcome doubt and family expectations.

Fill in the gaps with the correct forms of the words. Nowadays, healthcare is changing rapidly due to advancements in technology. Innovations in artificial intelligence and imaging technologies help doctors diagnose diseases (ACCURATELY). Preventative medicine(BECOME) more common as wearable devices monitor health in real time. AI analyzes large amounts of patient data to predict potential health issues before they become serious. Robotics and nanobots are playing an increasing role in (SURGERY)and targeted treatments. The market for the Internet of Medical Things (BE) worth over $85 billion by 2027. As technology continues to evolve, digital healthcare solutions will transform the way patients receive treatment. To keep up with (THIS) changes, healthcare professionals need to adapt to new tools and methods that improve patient outcomes.

Fill in the gaps with the correct derivatives of the words in brackets. 1. He was accepted into a (PRESTIGE) university known for its advancements in robotics. 2. The rapid (GROW) of biotechnology is revolutionizing modern medicine. 3. This company is known for its (INNOVATION) approach to architecture and design. 4. Sending humans to Mars was once thought to be (POSSIBLE), but now it's within reach. 5. Scientists are testing a new cancer (TREAT) that targets diseased cells more precisely. 6. Advances in (IMAGE) technologies have improved early disease detection.

Listen to the interview and choose the TRUE statements about Lucas.

Match the paragraphs to the technologies. There is one extra option.

Match the interview questions to the answers.

Read the statements after each paragraph and choose the correct options. Nanotechnology is revolutionizing the field of medicine, offering groundbreaking solutions for diagnosing and treating diseases. One of the most promising advancements involves nanoparticles—tiny spheres capable of carrying drugs directly to diseased cells. These particles, thousands of times smaller than the width of a human hair, can circulate through the body, delivering targeted treatments while minimizing side effects. This technology is not entirely new. In fact, the first nanoparticle-based drug, Doxil, was approved in 1994. Doxil is a liposomal formulation of the chemotherapy drug doxorubicin. It uses tiny fat-based particles to carry the drug, allowing for more efficient targeting of cancer cells. Since then, a variety of nanoparticle-based treatments have been developed, with clinical trials exploring their use in cancer therapy, pain management, and autoimmune diseases. The first medicine based on nanoparticles was developed to treat diabetes. However, the latest developments represent a new era in nanomedicine. Scientists at leading research institutions and biotech companies are creating nanoparticles equipped with homing molecules. These homing molecules are so named because they act like a GPS, guiding the particles to specific targets in the body. Much like how birds return to their home during migration, these molecules help the nanoparticles find and attach to cancerous cells, allowing them to deliver drugs with pinpoint precision and reduce harm to healthy tissues. For example, researchers at the University of California, San Diego, have developed a nanoparticle that can target cancer cells and release chemotherapy drugs only when it reaches the tumor. This reduces the side effects commonly associated with traditional chemotherapy, such as nausea, hair loss, and immune system suppression. In preclinical trials, these nanoparticles showed promising results in treating breast cancer and melanoma. Homing molecules can navigate the human body targeting specific areas. Even more futuristic are nanobots—microscopic robots capable of performing complex tasks inside the body. Some experimental nanobots can locate cancer cells, capture them, and report back with information. Others mimic natural human cells, such as red blood cells, to circulate longer in the bloodstream. For example, researchers at the University of Washington are developing nanoscale robots capable of delivering drugs to cancer cells by traveling through the bloodstream. These nanobots are made from DNA and can be programmed to bind to specific molecules, helping to target and treat disease more precisely. The nanobots that mimic the red blood cells can stay in the bloodstreem for about three months. While these technologies are still in clinical trials, experts predict that the first targeted nanoparticle treatments could be commercially available within the next decade. In fact, some companies are already conducting Phase 2 clinical trials with targeted nanoparticle drugs. One such drug is being tested for the treatment of solid tumors and has shown a higher rate of success in delivering drugs directly to the cancer cells, without the usual damage to surrounding healthy tissue. Some developments have proven to be quite effective in combating malignant body tissues. Many researchers believe that nanomedicine has the potential to turn cancer into a manageable chronic condition rather than a fatal disease. The technology offers hope for people suffering from difficult-to-treat cancers, such as pancreatic cancer, which is often diagnosed at an advanced stage, making it challenging to treat with conventional therapies. As a result, pancreatic cancer has one of the lowest survival rates among all cancers, with only 11% of patients surviving beyond five years after diagnosis. Traditional treatments, such as surgery, chemotherapy, and radiation, are often less effective due to the cancer’s aggressive nature and late detection. However, nanomedicine may provide a breakthrough by delivering targeted treatments directly to cancer cells while minimizing damage to healthy tissues. It is believed that nanomedicine can contribute to the early diagnostics of the pancreatic cancer. The future of medicine is rapidly evolving, and nanotechnology may soon redefine how we diagnose, treat, and even prevent life-threatening illnesses. With ongoing advancements in this field, there is optimism that nanomedicine will not only improve the precision of medical treatments but also make healthcare more personalized and accessible to patients around the world. The healthcare sector will tailor treatments to an individual’s unique characteristics.